Ledger.Open graph →
SEC Form D · filed February 11, 2022

Triana Biomedicines, Inc

Offering
$80.0M
Sold
$34.8M
Exemption
Rule 506(b)
Industry
Pharmaceuticals
Location
Waltham, MA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (18)

Richard Y. Bilotti · Piedmont, CADirectorTom B. Mccandless · Vancouver, British Columbia, CanadaDirectorJonathan Lamb · New York, NYDirectorPatrick Trojer · Waltham, MAExec · DirectorSimon Read · Waltham, MADirectorJoshua Resnick · Waltham, MADirectorRonald Rosenfarb · CAROLINA, Puerto RicoDirectorGrady J. Gaynor · Carmel, INDirectorNathan Mcgill · Columbus, OHExec · DirectorMilind Deshpande · Waltham, MADirectorPeter Rozenauers · New York, NYDirectorJay A. Brammer · Carmel, INDirectorMichael Esposito · Redondo Beach, CADirectorShelley Chu · Waltham, MADirectorOskar Lewnowski · New York, NYExec · DirectorEthan Y. Huynh · Piedmont, CADirectorAndrew P. Walrath · Schenectady, NYDirectorDavid Grayzel · Waltham, MADirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗